TG Therapeutics Inc
Most Recent
Robust Research Pipeline May Drive TG Therapeutics’ Future Growth
TG Therapeutics is a clinical-stage biopharmaceutical company mainly focused on developing innovative therapies for B-cell cancers and immunology conditions.
Why Spectrum Pharmaceuticals Stock Rose ~5% on September 6
On September 6, Spectrum Pharmaceuticals stock closed at $22.25, which is a ~5.70% rise from the prior day’s close of $21.05.
